| 000 | 01040nam a2200361 a 4500 | ||
|---|---|---|---|
| 001 | vtls000005996 | ||
| 003 | NLI | ||
| 005 | 20210601180529.0 | ||
| 008 | 101125s1977 nyu 001 0 eng | ||
| 020 |
_a082479981X _c$125.00 |
||
| 039 | 9 |
_y201011250024 _zVLOAD |
|
| 040 | 0 |
_aNLI _beng _cVERGIS-2003 |
|
| 041 | 0 | _aeng | |
| 044 | _anyu | ||
| 082 | 0 | 4 | _a615.6 |
| 245 | 0 | 0 |
_aDevelopment of biopharmaceutical parenteral dosage forms/ _cedited by John A. Bontempo |
| 260 |
_aNew York: _bMarcel Dekker, _c1977 |
||
| 300 |
_aix, 248 p.; _c22 cm. |
||
| 440 | 0 |
_aDrugs and the pharmaceutical science _v85 _922144 |
|
| 500 | _aIncludes index | ||
| 650 | 0 |
_aPharmaceutical biotechnology _922145 |
|
| 650 | 0 |
_aParenteral solutions _922146 |
|
| 700 | 1 |
_aBontempo, John A., _4edt _922147 |
|
| 887 | _aKannaki | ||
| 901 |
_a535893 _b26/04/2000 |
||
| 902 | _aE 615.6 D492 | ||
| 903 | _a19/02/2004 | ||
| 904 | _aKannaki | ||
| 906 | _a004158 | ||
| 949 |
_AVIRTUAITEM _D10000 _F1 _X100 _6PUR000535893ENG |
||
| 942 |
_2ddc _cBKS |
||
| 999 |
_c9783 _d9783 |
||